Important note: Information in this article was accurate in August 2004. The state of the art may have changed since the publication date.
 |
HIV Treatment Bulletin - Vol. 5, No. 7, August/September 2004
Chiron Corp plans a change in the licensing policy on its patents covering the genetic makeup of the hepatitis C virus, a move that they say could lead to the development of new drugs to fight the disease.
Scientists at Chiron were the first to identify hepatitis C virus in 1987, and the company has more than 100 patents on the virus’ genome, many of which still have over 10 years to run. Tight control of these patents and high licensing fees have often been claimed to limit research into new therapeutic treatments, including in a report by the National Academy of Sciences on intellectual property rights.
Chiron has now decided to no longer demand that licensors pay upfront fees and make annual payments to obtain rights to the hepatitis C patents.
Chiron, which is working on a vaccine and drug for hepatitis C, has licensed its patents to 15 other companies. Chiron had revenue of $1.8 billion last year, of which $312.2 million was royalties, mostly from licences on hepatitis C, HIV and a drug used to treat multiple sclerosis,
Source: Denise Gellene, "Chiron Relaxes Patent Licenses" LA Times 2004 June 22;C1
040810
IB040507-27
©2004. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
